what is a cryptocurrency market- Top Knowledge

Molding technology: The transaction amount of selling Jiangsu Bank shares was 226 million yuan. According to the announcement of molding technology, the company sold 25 million shares of Jiangsu Bank through centralized bidding from December 4, 2024 to December 11, 2024, with a transaction amount of 226 million yuan. After the sale, the company also holds 25,000,600 shares of Jiangsu Bank. This transaction is conducive to optimizing the company's asset structure, revitalizing existing assets, improving asset liquidity and efficiency, and meeting the company's capital needs for future development. The sale is expected to have a positive impact on the company's financial position and cash flow.On the 11th, iron ore fell by 1.64%, and the latest main contract positions changed as follows. According to the exchange data, as of December 11th, the main contract iron ore was closed at 2501, up or down by -1.64%, with a turnover of 165,400 lots. The position data showed that the top 20 seats were clear, and the difference position was 14,975 lots. Iron ore futures contracts totaled 429,100 lots, a decrease of 195,200 lots from the previous day. The first 20 seats in the contract held 462,200 lots, a decrease of 6,055 lots from the previous day. There were 481,400 short positions in the top 20 seats of the contract, an increase of 7,172 lots over the previous day. (Sina Futures)Guotai Junan expects Hong Kong stocks to fluctuate upward in an N-shaped pattern next year to explore domestic demand and improve investment opportunities. Chen Ximiao, chief analyst of Guotai Junan's overseas strategy, said that looking forward to 2025, the disturbance factors in the Hong Kong stock market from the external environment will continue, and the pace of interest rate cuts by the Federal Reserve under overseas inflation, policy restrictions in areas such as strong US dollar and tariffs, and game friction among big countries will continue. However, the domestic policy thinking is clear, economic expectations are expected to stabilize under the financial impetus, and the profitability of molecular enterprises will improve, and the industrial chain will be able to cope with it. She said that in 2025, the sensitivity of the Hong Kong stock market to external shocks is expected to decline, and more attention should be paid to returning to its own logic. For the trend of Hong Kong stocks in 2025, it is expected to be dominated by the upward pattern of N-shaped shocks, and there are many opportunities for flexibility during the stage. In 2025, we should still actively look for the structure, and focus on the barbell strategy to shift the weight of the two ends. We need to pay more attention to the configuration rhythm and pay attention to the repair opportunities of some domestic products.

Modern Pharmaceuticals: Sinopharm Zhijun, the holding subsidiary, obtained the drug registration certificate of Cefotaxime Tablets. Modern Pharmaceuticals announced that Sinopharm Zhijun Pharmaceutical Co., Ltd., the holding subsidiary, recently received the Drug Registration Certificate of Cefotaxime Tablets approved and issued by National Medical Products Administration. Cefopoxime axetil tablets are the third generation cephalosporins taken orally, which are used to treat upper respiratory tract infections and lower respiratory tract infections caused by sensitive bacteria. In 2023, the global sales of preparations will be USD 370 million, and the sales of public hospitals nationwide will be RMB 102 million. The accumulative R&D investment of Sinopharm Zhijun is about RMB 28.45 million. Obtaining the registration certificate will enrich the company's product line, increase market competitiveness and have a positive impact on the company's future development. However, drug sales are easily affected by factors such as policies and market environment, and there are uncertainties.On the 11th, the glass fell by 1.20%, and the latest main contract positions changed as follows. According to the exchange data, as of December 11th, the main contract glass 2501 closed, up or down by -1.20%, with a turnover of 365,200 lots. The position data showed that the top 20 seats were clear, and the difference position was 73,552 lots. The total turnover of glass futures contracts was 754,900 lots, a decrease of 1,229,700 lots from the previous day. The first 20 seats in the contract held 600,900 lots, an increase of 3,641 lots over the previous day. Short positions in the top 20 seats of the contract were 707,300 lots, an increase of 13,900 lots over the previous day. (Sina Futures)Meifeng, Sichuan: The wellhead natural gas trial production and recovery project has entered the trial production stage. meifeng, Sichuan announced that the trial production and recovery project of "Jinshi 103 Well" invested and built by Dongcai Shuangrui has completed the joint commissioning, and the trial production LNG products meet the requirements of national standards and are now entering the trial production stage. The total investment of the project is about 70 million yuan, and the main construction content is a set of wellhead gas trial production recovery device with a daily processing capacity of 200,000 m and supporting utilities and auxiliary facilities.

The change of industrial metal plate increased the daily limit of Liyuan shares, and the change of industrial metal plate increased the daily limit of Liyuan shares. Yun Aluminum shares rose by more than 7%, and Huafeng Aluminum, Shenhuo, Northern Copper and Yiqiu Resources followed suit.Sichuan Bank successfully issued 5.4 billion tier-2 capital bonds for the first time, with a subscription multiple of 6.6 times. Sichuan Bank completed its first capital bond issuance on December 10th. According to the information released by China Foreign Exchange Trading Center, the scale of Tier 2 capital bonds issued by Sichuan Bank this time is 5.4 billion yuan, and the subscription multiple is as high as 6.6 times, while that of coupon rate is 2.20%, with a term of 5+5 years. This bond attracted more than 100 institutional investors including banks, brokers, funds, trusts and wealth management subsidiaries to participate in the subscription, with a cumulative investment of more than 35 billion yuan.It is reported that Walgreens Boots Alliance is negotiating to sell itself to a private equity company, which will delist the drugstore chain. The company's share price has been declining for nearly ten years. According to informed sources, Wobolian and Sycamore Partners have been discussing a deal, which may be completed as early as early next year, provided that the negotiations do not break down. It is reported that the market value of Wobolian peaked at more than 100 billion US dollars in 2015, but it has shrunk to about 7.5 billion US dollars since then.